Olga E. Perchatkina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Olga E. Perchatkina has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Nikolay Aleksandrovich Bokhan
Mental Health Research Institute — Tomsk National Research Medical Center Russian Academy of Sciences
10 shared publications - M. F. Belokrylova
Mental Health Research Institute; Tomsk National Research Medical Center of the Russian Academy of Sciences; Siberian State Medical University of the Ministry of Health of the Russian Federation
9 shared publications - Mikhail M. Aksenov
Tomsk National Research Medical Center of the Russian Academy of Sciences
9 shared publications - V. A. Rudnitsky
Mental Health Research Institute; Tomsk National Research Medical Center of the Russian Academy of Sciences; Siberian State Medical University of the Ministry of Health of the Russian Federation
9 shared publications - Valentina Borisovna Nikitina
Tomsk National Research Medical Center, Russian Academy of Sciences, Mental Health Research Institute
9 shared publications - Tamara Parfenovna Vetlugina
Mental Health Research Institute, Tomsk National Research Medical Center (NRMC), Russian Academy of Sciences
6 shared publications
Latest Publications
- 14 July 2026
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 2(131)
The fundamental contribution of the Mental Health Research Institute to the establishment of academic foundations and traditions of a scientific approach in Siberia and the Far East, and to the coordination of research activities in psychiatry and Narcology
- 14 July 2026
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 2(131)
The fundamental contribution of the Mental Health Research Institute to the establishment of academic foundations and traditions of a scientific approach in Siberia and the Far East, and to the coordination of research activities in psychiatry and Narcology
- Open Access
- 23 September 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (4) , 171-181
Predicting the risk of the formation of mixed anxiety and depressive disorders in women
Background. In case of unfavorable dynamics of events and/or untimely treatment; adjustment disorders may develop into more severe conditions with aggravated clinical manifestations. The reaction to stress becomes prolonged and goes beyond the adjustment disorders; leading to the formation of stable psychopathological disorders with a predominance of vegetative symptoms. A mixed anxiety and depressive reaction due to adjustment disorders may transform into a clinically formalized mixed anxiety and depressive disorder.The aim. Construction of a mathematical model for predicting the risk of developing the mixed anxiety and depressive disorder in women with mixed anxiety and depressive reaction due to adjustment disorders; using hormonal parameters.Materials and methods. Two groups of women were examined: group 1 (n = 53) with the diagnosis of “Adjustment disorders: mixed anxiety and depressive reaction” (F43.22); group 2 (n = 48) – “Mixed anxiety and depressive disorder” (F41.2). The level of anxiety was determined using the Spielberger – Khanin Personality and Reactive Anxiety subscale. Anxiety and depression levels were assessed using the Hospital Anxiety and Depression Scale (HADS). The body mass index (BMI) was calculated. The laboratory study included the determination of hormonal parameters using the ELISA method. All data were processed statistically.Results. A model for predicting the risk of developing mixed anxiety and depressive disorder in women with mixed anxiety and depressive reaction due to adjustment disorder had been developed. The model included the level of cortisol; prolactin; and BMI. The criterion variable was calculated; and if its value was ≥ 1.5; the risk of developing mixed anxiety and depressive disorder was predicted; and if the value was < 1.5; a favorable course of adjustment disorder was predicted with 83.0 % sensitivity – 81.3 % specificity.Conclusion. We propose a mathematical model that provides the possibility of early recognition of conditions with a high risk of developing mixed anxiety and depressive disorder. This will allow timely carrying out the preventive and therapeutic activities aimed at increasing the stress resistance and restoring the normal neuroendocrine regulation.
- 23 September 2025
- Published by FSPSI SCFHHRP in Acta Biomedica Scientifica
- Vol. 10 (4) , 171-181
Open AccessPredicting the risk of the formation of mixed anxiety and depressive disorders in women
Background. In case of unfavorable dynamics of events and/or untimely treatment; adjustment disorders may develop into more severe conditions with aggravated clinical manifestations. The reaction to stress becomes prolonged and goes beyond the adjustment disorders; leading to the formation of stable psychopathological disorders with a predominance of vegetative symptoms. A mixed anxiety and depressive reaction due to adjustment disorders may transform into a clinically formalized mixed anxiety and depressive disorder.The aim. Construction of a mathematical model for predicting the risk of developing the mixed anxiety and depressive disorder in women with mixed anxiety and depressive reaction due to adjustment disorders; using hormonal parameters.Materials and methods. Two groups of women were examined: group 1 (n = 53) with the diagnosis of “Adjustment disorders: mixed anxiety and depressive reaction” (F43.22); group 2 (n = 48) – “Mixed anxiety and depressive disorder” (F41.2). The level of anxiety was determined using the Spielberger – Khanin Personality and Reactive Anxiety subscale. Anxiety and depression levels were assessed using the Hospital Anxiety and Depression Scale (HADS). The body mass index (BMI) was calculated. The laboratory study included the determination of hormonal parameters using the ELISA method. All data were processed statistically.Results. A model for predicting the risk of developing mixed anxiety and depressive disorder in women with mixed anxiety and depressive reaction due to adjustment disorder had been developed. The model included the level of cortisol; prolactin; and BMI. The criterion variable was calculated; and if its value was ≥ 1.5; the risk of developing mixed anxiety and depressive disorder was predicted; and if the value was < 1.5; a favorable course of adjustment disorder was predicted with 83.0 % sensitivity – 81.3 % specificity.Conclusion. We propose a mathematical model that provides the possibility of early recognition of conditions with a high risk of developing mixed anxiety and depressive disorder. This will allow timely carrying out the preventive and therapeutic activities aimed at increasing the stress resistance and restoring the normal neuroendocrine regulation.
- 3 April 2025
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 1(126)
Иммунобиологическая модель диагностики течения расстройства адаптации у женщин
- 3 April 2025
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 1(126)
Иммунобиологическая модель диагностики течения расстройства адаптации у женщин
- 11 February 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (1) , 112-118
Indicators of the background spectral power of the EEG in patients with alcohol dependence complicated by exogenous organic brain disease
Objective. To conduct a comparative analysis of EEG spectral power indicators in patients with alcoholism with- or without exogenous organic brain disease. Material and methods. An analysis of 119 EEG of patients with alcohol dependence was carried out. The presence of exogenous organic brain disease in patients was assessed retrospectively (through anamnesis). The EEG signals received from 16 electrodes were first divided into 3 frequency spectra (i.e. theta, alpha and beta), then the values of absolute spectral power were calculated, and then they were reordered, combined and topographically transferred to a spectral map. Data analysis was carried out in 5 different ways: electrode analysis, analysis based on cortical regions, lateralization, antero-posterior locus and throughout the whole cortex. Results. In the group of alcohol-dependent patients with comorbid exogenous organic brain damage, significantly (p<0.05) lower values of the spectral power of alpha activity on the Fp2, F3, F4, C3 and C4 electrodes as well as higher values of the spectral power of beta activity on the F8, T5 and T6 electrodes compared with the group of patients with «pure» alcohol dependence were observed. The intergroup data analysis, taking into account the topographic distribution, revealed significant differences in the spectral power of alpha activity in the prefrontal (F=4.201; p=0.043), frontal (F=3.951; p=0.049), central (F=4.033; p=0.047) and parietal (F=3.926; p=0.049) regions, as well as beta activity in the temporal region (F=5.656; p=0.019) of the cerebral cortex. Compared with patients suffering only from alcohol dependence, the group of patients with alcohol dependence and exogenous organic brain damage had significantly lower spectral power of alpha activity on the left (F=5.329; p=0.019) and on the right (F=5.191; p=0.027), as well as in the anterior locus (F=3.975; p=0.049). Conclusion. The results clearly indicate that the presence of exogenous organic brain damage in patients with alcohol dependence is accompanied by a change in the spectral power of the EEG mainly in the alpha frequency range.
- 11 February 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (1) , 112-118
Indicators of the background spectral power of the EEG in patients with alcohol dependence complicated by exogenous organic brain disease
Objective. To conduct a comparative analysis of EEG spectral power indicators in patients with alcoholism with- or without exogenous organic brain disease. Material and methods. An analysis of 119 EEG of patients with alcohol dependence was carried out. The presence of exogenous organic brain disease in patients was assessed retrospectively (through anamnesis). The EEG signals received from 16 electrodes were first divided into 3 frequency spectra (i.e. theta, alpha and beta), then the values of absolute spectral power were calculated, and then they were reordered, combined and topographically transferred to a spectral map. Data analysis was carried out in 5 different ways: electrode analysis, analysis based on cortical regions, lateralization, antero-posterior locus and throughout the whole cortex. Results. In the group of alcohol-dependent patients with comorbid exogenous organic brain damage, significantly (p<0.05) lower values of the spectral power of alpha activity on the Fp2, F3, F4, C3 and C4 electrodes as well as higher values of the spectral power of beta activity on the F8, T5 and T6 electrodes compared with the group of patients with «pure» alcohol dependence were observed. The intergroup data analysis, taking into account the topographic distribution, revealed significant differences in the spectral power of alpha activity in the prefrontal (F=4.201; p=0.043), frontal (F=3.951; p=0.049), central (F=4.033; p=0.047) and parietal (F=3.926; p=0.049) regions, as well as beta activity in the temporal region (F=5.656; p=0.019) of the cerebral cortex. Compared with patients suffering only from alcohol dependence, the group of patients with alcohol dependence and exogenous organic brain damage had significantly lower spectral power of alpha activity on the left (F=5.329; p=0.019) and on the right (F=5.191; p=0.027), as well as in the anterior locus (F=3.975; p=0.049). Conclusion. The results clearly indicate that the presence of exogenous organic brain damage in patients with alcohol dependence is accompanied by a change in the spectral power of the EEG mainly in the alpha frequency range.
- 27 December 2024
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 4(125)
Влияние фармакотерапии на фармакокинетические параметры модельного субстрата антипирина – тест-свидетеля процессов элиминации ксенобиотиков в слюне у пациентов с психическими расстройствами
- 27 December 2024
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 4(125)
Влияние фармакотерапии на фармакокинетические параметры модельного субстрата антипирина – тест-свидетеля процессов элиминации ксенобиотиков в слюне у пациентов с психическими расстройствами
- 13 November 2024
- Published by ECO-Vector LLC in Reviews on Clinical Pharmacology and Drug Therapy
- Vol. 22 (3) , 319-334
Influence of pharmacotherapy on function of biotransformation of xenobiotics liver in patients with neuropsychiatric disorders
BACKGROUND: The mechanisms of drug interactions of psychotropic drugs are associated with the processes of drug biotransformation by enzymes of microsomal oxidation of cytochrome P-450 in the liver. Various drugs can increase or decrease the activity of enzymes of the cytochrome P450-dependent system. AIM: To evaluate the effect of pharmacotherapy with psychotropic drugs: alprazolam, bromazepam, lithium carbonate on the metabolic rate of the model substrate antipyrine in saliva in patients with neuropsychiatric disorders; the effect of the enzyme-inducing activity of the original anticonvulsant 1-[(3-chlorophenyl)(phenyl)methyl]urea on the pharmacokinetic parameters of antipyrine in healthy volunteers. MATERIALS AND METHODS: 34 male patients were divided into three groups according to the nosological forms of diseases according to ICD-10: Group 1 — heading F43.23 and F43.25; 2 — F06.61; 3 — F41.2. Patients in the group 1 were prescribed alprazolam, in the 2 — bromazepam, in the 3 — lithium carbonate, for a course of 21 days. The comparison group consisted of 10 healthy volunteers. The original anticonvulsant was prescribed to the volunteers. Determination of the pharmacokinetics of antipyrine parameters as a test witness of the processes of elimination from the body was carried out in saliva before and after the end of therapy at a dose of 10 mg/kg once. RESULTS: Alprazolam administration by patients of group 1 at a dose of 0.5–1.5 mg/day for 21 days did not significantly affect the pharmacokinetic parameters of antipyrine: T1/2, Clt, AUC. Alprazolam did not change the elimination of antipyrine from the saliva of patients. In patients of the group2, who received bromazepam at a dose of 6–12 mg / day,a background decrease in T1/2, an increase in Clt, a decrease in AUC due to concomitant therapy were noted. Comparison of the pharmacokinetic parameters of antipyrine under the influence of bromazepam with background values not reveal significant differences. Therapy with lithium carbonate at a dose of 500–1000 mg/day in patients of the group 3 did not change the parameters of antipyrine elimination. The obtained data indicate that the drugs do not affect the activity of liver microsomal oxidation in patients. The study of the effect of 1-[(3-chlorophenyl)(phenyl)methyl]urea on the pharmacokinetic parameters of antipyrine in volunteers revealed a diametrically opposite result: a significant decrease in T1/2 by 2 times, an increase in Clt and a decrease in AUC, which indicates accelerated elimination of antipyrine from the saliva of the subjects and indicates the induction of liver microsomal oxidation. CONCLUSIONS: Pharmacotherapy using the studied psychotropic drugs in patients is not associated with the induction or inhibition of liver enzymes, which indicates the absence of drug pharmacokinetic interference. The original anticonvulsant 1-[(3-chlorophenyl)(phenyl)methyl]urea stimulated the induction of liver microsomal oxidation in volunteers.
- 13 November 2024
- Published by ECO-Vector LLC in Reviews on Clinical Pharmacology and Drug Therapy
- Vol. 22 (3) , 319-334
Influence of pharmacotherapy on function of biotransformation of xenobiotics liver in patients with neuropsychiatric disorders
BACKGROUND: The mechanisms of drug interactions of psychotropic drugs are associated with the processes of drug biotransformation by enzymes of microsomal oxidation of cytochrome P-450 in the liver. Various drugs can increase or decrease the activity of enzymes of the cytochrome P450-dependent system. AIM: To evaluate the effect of pharmacotherapy with psychotropic drugs: alprazolam, bromazepam, lithium carbonate on the metabolic rate of the model substrate antipyrine in saliva in patients with neuropsychiatric disorders; the effect of the enzyme-inducing activity of the original anticonvulsant 1-[(3-chlorophenyl)(phenyl)methyl]urea on the pharmacokinetic parameters of antipyrine in healthy volunteers. MATERIALS AND METHODS: 34 male patients were divided into three groups according to the nosological forms of diseases according to ICD-10: Group 1 — heading F43.23 and F43.25; 2 — F06.61; 3 — F41.2. Patients in the group 1 were prescribed alprazolam, in the 2 — bromazepam, in the 3 — lithium carbonate, for a course of 21 days. The comparison group consisted of 10 healthy volunteers. The original anticonvulsant was prescribed to the volunteers. Determination of the pharmacokinetics of antipyrine parameters as a test witness of the processes of elimination from the body was carried out in saliva before and after the end of therapy at a dose of 10 mg/kg once. RESULTS: Alprazolam administration by patients of group 1 at a dose of 0.5–1.5 mg/day for 21 days did not significantly affect the pharmacokinetic parameters of antipyrine: T1/2, Clt, AUC. Alprazolam did not change the elimination of antipyrine from the saliva of patients. In patients of the group2, who received bromazepam at a dose of 6–12 mg / day,a background decrease in T1/2, an increase in Clt, a decrease in AUC due to concomitant therapy were noted. Comparison of the pharmacokinetic parameters of antipyrine under the influence of bromazepam with background values not reveal significant differences. Therapy with lithium carbonate at a dose of 500–1000 mg/day in patients of the group 3 did not change the parameters of antipyrine elimination. The obtained data indicate that the drugs do not affect the activity of liver microsomal oxidation in patients. The study of the effect of 1-[(3-chlorophenyl)(phenyl)methyl]urea on the pharmacokinetic parameters of antipyrine in volunteers revealed a diametrically opposite result: a significant decrease in T1/2 by 2 times, an increase in Clt and a decrease in AUC, which indicates accelerated elimination of antipyrine from the saliva of the subjects and indicates the induction of liver microsomal oxidation. CONCLUSIONS: Pharmacotherapy using the studied psychotropic drugs in patients is not associated with the induction or inhibition of liver enzymes, which indicates the absence of drug pharmacokinetic interference. The original anticonvulsant 1-[(3-chlorophenyl)(phenyl)methyl]urea stimulated the induction of liver microsomal oxidation in volunteers.